Adma projects 2026 revenue of $530M-$560M and withdraws longer-term guidance amid standard IG dislocation
ADMA Biologics, Inc. · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $7.90
-3.5% in 1d after detection
Post-detection moves
1h
—
1d
-3.5%
3d
-0.7%
7d
-1.1%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS